First new Asthma attack Treatment in 50 years

What causes to have asthma?

Researchers have conducted some research about asthma, and they are predicting this can be the cause 

for children or adults to have asthma.

Family background

If you have an asthmatic parent, you are three to six times more likely to get asthma than if you don't have one. Allergies Some people are more prone to developing allergies than others, particularly if one of their parents is allergic. 

Occupational Exposures

If you have asthma, exposure to specific substances at work may aggravate your symptoms. In addition, for certain people, exposure to specific dusts (industrial or wood dusts), chemical fumes and vapors, and molds might cause asthma to develop for the first time.

Cigarette smoke can irritate the airways. Those whose moms smoked while pregnant or who were exposed to secondhand smoke are also more likely to develop asthma. 

Air Pollution

Exposure to ozone, the major component of smog, increases the risk of asthma. People who grew up or resided in cities are more likely to get asthma.

This can be a great discovery and life-changing movement for asthma patients, The injection dampens the part of the immune system that can flare up both the asthma and the lungs this is called COPD(chronic obstructive pulmonary disease). Benralizumab is now used for the most severe cases, but according to recent studies it may be used regularly for almost two million attacks annually in the UK. King's College London researchers described the medicine as a "game-changer" with the potential to "revolutionize" care. The conclusions come from recognizing that not all asthma or COPD (chronic obstructive pulmonary disease) attacks are the same. Instead, various immune system components overreact in different patients."Now we can see there are different patterns of inflammation, we can be smarter and get the right treatment, to the right patient, at the right time," 

If an attack involving breathing difficulties, wheezing, coughing, and tightness in the chest cannot be managed with standard inhalers, doctors currently prescribe a course of steroids. The study, which included 158 participants, followed patients for three months after therapy for a flare-up. The findings in The Lancet Respiratory Medicine revealed a treatment failure rate of 74% when using steroids and 45% with the new therapy. Patients receiving the new therapy were less likely to be admitted to the hospital, require additional treatment, or die.